Tenax Therapeutics Inc (TENX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $73.77M
Last updated: Nov 17, 2026 at 11:05 AM ET
Tenax Therapeutics Inc (TENX) Earnings: Report Dates and Results
Tenax Therapeutics (TENX) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Tenax Therapeutics reported EPS of -$0.31, above the -$0.35 estimate. It beat the EPS estimate in each of the last 10 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TENX has an expected report date of Mar 8, 2027.
Earnings History
Of the 40 quarters below that had an estimate, TENX beat 25, missed 14 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 680.95% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.31 | -$0.35 | -$0.39 - -$0.33 | +11.43% | Beat | N/A | 7 | 4 up, 1 down | Nov 5, 2026 |
| Jun 30, 2026 | -$0.35 | -$0.38 | -$0.42 - -$0.31 | +7.89% | Beat | N/A | 7 | 0 up, 0 down | Jul 31, 2026 |
| Mar 31, 2026 | -$0.35 | -$0.40 | -$0.43 - -$0.35 | +12.50% | Beat | N/A | 6 | 1 up, 1 down | May 12, 2026 |
| Dec 31, 2025 | -$0.38 | -$0.42 | -$0.43 - -$0.41 | +8.43% | Beat | N/A | 4 | 0 up, 2 down | Mar 10, 2026 |
| Sep 30, 2025 | -$0.40 | -$1.12 | -$4.37 - -$0.30 | +64.29% | Beat | N/A | 5 | 1 up, 3 down | Nov 12, 2025 |
| Jun 30, 2025 | -$0.27 | -$0.45 | -$1.07 - -$0.19 | +40.00% | Beat | N/A | 4 | 1 up, 3 down | Aug 13, 2025 |
| Mar 31, 2025 | -$0.28 | -$0.41 | -$1.06 - -$0.19 | +31.71% | Beat | N/A | 4 | 1 up, 2 down | May 14, 2025 |
| Dec 31, 2024 | -$0.18 | -$0.43 | -$1.23 - -$0.14 | +57.65% | Beat | N/A | 4 | 2 up, 0 down | Mar 25, 2025 |
| Sep 30, 2024 | -$0.19 | -$1.37 | -$1.62 - -$1.16 | +86.13% | Beat | N/A | 5 | 0 up, 0 down | Nov 13, 2024 |
| Jun 30, 2024 | -$1.83 | -$2.25 | -$2.25 - -$1.72 | +18.67% | Beat | N/A | 2 | 0 up, 0 down | Aug 13, 2024 |
| Mar 31, 2024 | -$3.12 | -$3.06 | -$3.06 - -$1.74 | -1.96% | Miss | N/A | 2 | 0 up, 0 down | May 14, 2024 |
| Dec 31, 2023 | -$12.98 | -$8.14 | -$9.33 - -$6.96 | -59.46% | Miss | N/A | 2 | 0 up, 0 down | Mar 28, 2024 |
| Sep 30, 2023 | -$6.40 | -$7.20 | -$9.60 - -$4.80 | +11.11% | Beat | N/A | 2 | 1 up, 0 down | Nov 13, 2023 |
| Jun 30, 2023 | -$4.00 | -$5.60 | -$10.40 - -$5.60 | +28.57% | Beat | N/A | 2 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$12.00 | -$29.60 | -$29.60 - -$29.60 | +59.46% | Beat | N/A | 1 | 0 up, 0 down | May 15, 2023 |
| Dec 31, 2022 | -$1.73 | -$2.28 | -$2.28 - -$2.28 | +24.12% | Beat | N/A | 1 | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$176.00 | -$176.00 | -$176.00 - -$160.00 | 0.00% | In line | N/A | 2 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$176.00 | -$144.00 | N/A | -22.22% | Miss | N/A | N/A | 0 up, 0 down | Aug 11, 2022 |
| Mar 31, 2022 | -$176.00 | -$144.00 | N/A | -22.22% | Miss | N/A | N/A | 0 up, 0 down | May 16, 2022 |
| Dec 31, 2021 | -$0.80 | -$3.20 | -$3.40 - -$3.00 | +75.00% | Beat | N/A | 2 | N/A | Mar 31, 2022 |
| Sep 30, 2021 | -$240.00 | -$208.00 | -$208.00 - -$208.00 | -15.38% | Miss | N/A | 2 | N/A | Nov 16, 2021 |
| Jun 30, 2021 | -$160.00 | -$256.00 | N/A | +37.50% | Beat | N/A | N/A | N/A | Aug 16, 2021 |
| Mar 31, 2021 | -$32.80 | -$4.20 | -$4.20 - -$4.20 | -680.95% | Miss | N/A | 1 | N/A | May 17, 2021 |
| Dec 31, 2020 | -$960.00 | -$288.00 | -$288.00 - -$160.00 | -233.33% | Miss | N/A | 2 | N/A | Mar 31, 2021 |
| Sep 30, 2020 | -$288.00 | -$256.00 | -$256.00 - -$208.00 | -12.50% | Miss | N/A | 2 | N/A | Nov 16, 2020 |
| Jun 30, 2020 | -$368.00 | -$320.00 | -$352.00 - -$320.00 | -15.00% | Miss | N/A | 2 | N/A | Aug 17, 2020 |
| Mar 31, 2020 | -$608.00 | -$304.00 | -$304.00 - -$304.00 | -100.00% | Miss | N/A | 1 | N/A | May 15, 2020 |
| Dec 31, 2019 | -$8.20 | -$12.10 | -$16.00 - -$8.20 | +32.23% | Beat | N/A | 2 | N/A | Mar 30, 2020 |
| Sep 30, 2019 | -$528.00 | -$496.00 | -$704.00 - -$496.00 | -6.45% | Miss | N/A | 2 | N/A | Nov 14, 2019 |
| Jun 30, 2019 | -$448.00 | -$576.00 | -$720.00 - -$576.00 | +22.22% | Beat | N/A | 2 | N/A | Aug 14, 2019 |
| Mar 31, 2019 | -$528.00 | -$544.00 | -$544.00 - -$544.00 | +2.94% | Beat | N/A | 1 | N/A | Apr 1, 2019 |
| Dec 31, 2018 | -$0.91 | -$6.20 | N/A | +85.32% | Beat | N/A | N/A | N/A | Mar 31, 2019 |
| Sep 30, 2018 | -$1,680.00 | -$2,336.00 | N/A | +28.08% | Beat | N/A | N/A | N/A | Nov 14, 2018 |
| Jun 30, 2018 | -$2,064.00 | -$1,600.00 | -$1,600.00 - -$1,600.00 | -29.00% | Miss | N/A | 1 | N/A | Aug 14, 2018 |
| Mar 31, 2018 | -$1,328.00 | -$1,712.00 | -$1,712.00 - -$1,712.00 | +22.43% | Beat | N/A | 1 | N/A | Apr 2, 2018 |
| Dec 31, 2017 | -$0.95 | -$1.60 | -$1.60 - -$1.60 | +40.94% | Beat | -101.8% | 1 | N/A | Mar 20, 2018 |
| Sep 30, 2017 | -$1,280.00 | -$2,240.00 | N/A | +42.86% | Beat | N/A | N/A | N/A | Nov 9, 2017 |
| Jun 30, 2017 | -$3,520.00 | -$2,880.00 | N/A | -22.22% | Miss | N/A | N/A | N/A | Aug 9, 2017 |
| Mar 31, 2017 | -$3,840.00 | -$3,200.00 | N/A | -20.00% | Miss | N/A | N/A | N/A | May 10, 2017 |
| Dec 31, 2016 | $52.00 | -$58.00 | N/A | +189.66% | Beat | +14344.4% | N/A | N/A | Mar 21, 2017 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.33, after -$5.32 the year before. It was -$16,268.00 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.33 | N/A |
| Dec 31, 2024 | -$5.32 | N/A |
| Dec 31, 2023 | -$35.38 | N/A |
| Dec 31, 2022 | -$529.73 | N/A |
| Dec 31, 2021 | -$433.60 | N/A |
| Dec 31, 2020 | -$2,224.00 | N/A |
| Dec 31, 2019 | -$1,512.20 | N/A |
| Dec 31, 2018 | -$5,072.91 | N/A |
| Dec 31, 2017 | -$8,640.95 | N/A |
| Dec 31, 2016 | -$16,268.00 | N/A |
Frequently Asked Questions About TENX
When is Tenax Therapeutics's next earnings date?
Tenax Therapeutics's next earnings report is expected for Mar 8, 2027.
Did TENX beat earnings estimates last quarter?
Yes. Tenax Therapeutics reported EPS of -$0.31 for the quarter ended Sep 30, 2026, above the -$0.35 estimate, a 11.43% surprise.
What EPS do analysts expect from TENX next quarter?
The consensus EPS estimate for Tenax Therapeutics for the quarter ending Dec 31, 2026 is -$0.36 from 10 analysts, with estimates from -$0.42 to -$0.21.
How often does TENX beat earnings estimates?
Tenax Therapeutics beat the EPS estimate in each of the last 10 quarters, with an average surprise of +33.87%.
TENX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors